Pfizer (PFE) Work In Process (2009 - 2019)
Pfizer (PFE) reported Work In Process of $5.2 billion for Q1 2019, up 15.54% year-over-year from $4.5 billion in Q1 2018, and up 10.23% on a QoQ basis from $4.7 billion in Q4 2018.
Pfizer (PFE) has 11 years of Work In Process data on file, last reported at $5.2 billion in Q1 2019.
- Quarterly Work In Process rose 15.54% year-over-year to $5.2 billion in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $5.2 billion (up 15.54% YoY) and the FY2018 annual result came in at $4.7 billion, up 20.29% from the prior year.
- Work In Process improved to $5.2 billion in Q1 2019 per PFE's latest filing, from $4.7 billion in the prior quarter.
- Across five years, Work In Process topped out at $5.2 billion in Q1 2019 and bottomed at $3.4 billion in Q1 2015.
- The 5-year median for Work In Process is $4.0 billion (2016), against an average of $4.2 billion.
- The widest annual swing landed in 2015, when Work In Process rose 21.06%; it then decreased 6.0% in 2016.
- Tracing PFE's Work In Process over 5 years: stood at $3.9 billion in 2015, then decreased by 6.0% to $3.7 billion in 2016, then increased by 5.74% to $3.9 billion in 2017, then gained by 20.29% to $4.7 billion in 2018, then increased by 10.23% to $5.2 billion in 2019.
- Per Business Quant, the three latest PFE Work In Process figures stand at $5.2 billion (Q1 2019), $4.7 billion (Q4 2018), and $4.8 billion (Q3 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 5.18 Bn |
| Dec 31, 2018 | 4.70 Bn |
| Sep 30, 2018 | 4.76 Bn |
| Jul 1, 2018 | 4.54 Bn |
| Apr 1, 2018 | 4.49 Bn |
| Dec 31, 2017 | 3.91 Bn |
| Dec 31, 2016 | 3.70 Bn |
| Oct 2, 2016 | 3.97 Bn |
| Jul 3, 2016 | 3.93 Bn |
| Apr 3, 2016 | 3.96 Bn |
| Dec 31, 2015 | 3.93 Bn |
| Sep 27, 2015 | 4.20 Bn |
| Jun 28, 2015 | 3.46 Bn |
| Mar 29, 2015 | 3.41 Bn |
| Dec 31, 2014 | 3.25 Bn |
| Sep 28, 2014 | 3.60 Bn |
| Jun 29, 2014 | 3.45 Bn |
| Mar 30, 2014 | 3.01 Bn |
| Dec 31, 2013 | 3.45 Bn |
| Sep 29, 2013 | 3.60 Bn |
| Jun 30, 2013 | 3.14 Bn |
| Mar 31, 2013 | 3.46 Bn |
| Dec 31, 2012 | 3.37 Bn |
| Sep 30, 2012 | 3.99 Bn |
| Jul 1, 2012 | 3.72 Bn |
| Apr 1, 2012 | 3.32 Bn |
| Dec 31, 2011 | 3.51 Bn |
| Oct 2, 2011 | 3.58 Bn |
| Jul 3, 2011 | 4.19 Bn |
| Apr 3, 2011 | 3.91 Bn |
| Dec 31, 2010 | 3.73 Bn |
| Oct 3, 2010 | 3.80 Bn |
| Jul 4, 2010 | 4.08 Bn |
| Dec 31, 2009 | 5.78 Bn |